The FDA and CDC found bacteria in three batches of preservative-free betamethasone and in a single batch of cardioplegia solution. The test results reinforce the lack of sterility in products manufactured by NECC and that healthcare providers should not use any of its products.
More Articles on Anesthesia:
Dicolfenac Provides Significant Pain Relief for Abdominal, Pelvic Surgeries
Can ASCs Still Profit From Anesthesia? A Review of OIG Guidance
Anesthesiologist Dr. Brian Waltmann Joins MedNet as Medical Director
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
